presented by Kate Hutcheson
This course, with Dr. Kate Hutcheson, is the second of a two part series for speech language pathologists covering radiation associated dysphagia, or RAD. In this installment, Dr. Hutcheson begins by describing evidence-based methods for evaluating RAD in patients, as well as prevention strategies for RAD. The final chapter of the series details evidence based management strategies for RAD. The course concludes with a discussion of prevention and management of RAD with Dr. Robert Miller, from the University of Washington. This course is designed to help the practicing SLP prevent and/or minimize RAD and develop strategies for the treatment of persistent or late RAD.
Kate A. Hutcheson, is an assistant professor in the Department of Head and Neck Surgery and associate director of research in the Section of Speech Pathology and Audiology at The University of Texas MD Anderson Cancer Center. Dr. Hutcheson graduated magna cum laude from Baylor University. She earned a master of science in communication sciences and disorders at Baylor and attained a PhD in epidemiology from the University of Texas School of Public Health in 2010. Dr. Hutcheson has authored over 40 peer-reviewed and invited articles on upper aerodigestive tract functioning in oncology patients. She is the recipient of the University of Texas Health Innovation for Cancer Prevention Research Fellowship Award supporting her work on late effects in head and neck cancer survivors. Dr. Hutcheson is a Board Certified Specialist in Swallowing and Swallowing Disorders (BCS-S) and expert in head and neck cancer rehabilitation.
In this chapter, Dr. Hutcheson reviews material from the first installment of the course series, describing the pathophysiology of RAD. She also elaborates on evidence-based evaluative tools for identifying the type and progression of RAD in head and neck cancer patients.
This chapter provides background and instruction on evidence-based management strategies for acute and late stage RAD. Approaches discussed include preventative therapy/supportive care, the baseline factors that influence management outcomes, and direct treatments such as exercise and device-driven therapies.
Dr. Hutcheson interviews Dr. Robert Miller to discuss issues around RAD and it’s management. Topics include new directions of research, and emerging therapies, and clinical anecdotes.